Clinical Trial Update: A Study to Learn How Safe the Study Treatment BAY2701250 is, How it Affects the Body and How it Moves Into, Through and Out of the Body in Healthy Male Participants When a Single Amount is Given as an Injection Into the Vein (Intravenous Infusion) or Under the Skin (Subcutaneous Injection) [Phase 1]

View source ↗

Summary

Phase 1 study assessing safety, pharmacokinetics, and body disposition of BAY2701250 given by IV or subcutaneous injection in healthy male participants, with Pu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension Due to Left Heart Disease

Drugs mentioned

• BAY2701250

Snippet

Sponsor: Bayer | Conditions: Pulmonary Hypertension Due to Left Heart Disease | Phase 1 | Status: COMPLETED